Insider Selling: NIOX Group (LON:NIOX) Insider Sells £154,688.80 in Stock

NIOX Group Plc (LON:NIOX) insider Ian Johnson sold 193,361 shares of NIOX Group stock in a transaction that occurred on Monday, November 2nd. The stock was sold at an average price of GBX 80, for a total transaction of £154,688.80.

NIOX Group Stock Up 2.6%

Shares of NIOX opened at GBX 64 on Friday. NIOX Group Plc has a 52 week low of GBX 53.84 and a 52 week high of GBX 80. The company has a quick ratio of 1.94, a current ratio of 4.60 and a debt-to-equity ratio of 1.06. The company has a market capitalization of £259.35 million, a price-to-earnings ratio of 39.26 and a beta of 0.92. The stock’s 50-day moving average price is GBX 67.09 and its 200-day moving average price is GBX 63.06.

NIOX Group (LON:NIOX) last issued its quarterly earnings results on Wednesday, September 30th. The company reported GBX 1.41 earnings per share (EPS) for the quarter. NIOX Group had a return on equity of 10.01% and a net margin of 14.74%. On average, sell-side analysts predict that NIOX Group Plc will post 1.17 EPS for the current year.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.